BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22591747)

  • 1. Simultaneous progression of oxidative stress, angiogenesis, and cell proliferation in prostate carcinoma.
    Pande D; Negi R; Karki K; Dwivedi US; Khanna RS; Khanna HD
    Urol Oncol; 2013 Nov; 31(8):1561-6. PubMed ID: 22591747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma.
    Guzel S; Kiziler L; Aydemir B; Alici B; Ataus S; Aksu A; Durak H
    Biol Trace Elem Res; 2012 Jan; 145(1):23-32. PubMed ID: 21809052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.
    Shariat SF; Anwuri VA; Lamb DJ; Shah NV; Wheeler TM; Slawin KM
    J Clin Oncol; 2004 May; 22(9):1655-63. PubMed ID: 15117988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
    Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
    Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma.
    Pande D; Negi R; Karki K; Khanna S; Khanna RS; Khanna HD
    Transl Res; 2012 Dec; 160(6):411-8. PubMed ID: 22885175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB p65 subunit DNA-binding activity: association with depleted antioxidant levels in breast carcinoma patients.
    Pande D; Karki K; Negi R; Khanna S; Khanna RS; Khanna HD
    Cell Biochem Biophys; 2013; 67(3):1275-81. PubMed ID: 23709312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
    Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
    Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia.
    Ahmad R; Tripathi AK; Tripathi P; Singh S; Singh R; Singh RK
    In Vivo; 2008; 22(4):525-8. PubMed ID: 18712183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of 8-oxo-7, 8-dihydro-2'-deoxyguanosine and malondialdehyde levels as oxidative stress markers and antioxidant status in non-small cell lung cancer.
    Peddireddy V; Siva Prasad B; Gundimeda SD; Penagaluru PR; Mundluru HP
    Biomarkers; 2012 May; 17(3):261-8. PubMed ID: 22397584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
    Fukuda H; Tsuchiya N; Narita S; Kumazawa T; Horikawa Y; Inoue T; Saito M; Yuasa T; Matsuura S; Satoh S; Ogawa O; Habuchi T
    Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.
    Tae K; El-Naggar AK; Yoo E; Feng L; Lee JJ; Hong WK; Hittelman WN; Shin DM
    Clin Cancer Res; 2000 Jul; 6(7):2821-8. PubMed ID: 10914730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study.
    Hietanen E; Bartsch H; Béréziat JC; Camus AM; McClinton S; Eremin O; Davidson L; Boyle P
    Eur J Clin Nutr; 1994 Aug; 48(8):575-86. PubMed ID: 7957003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and antioxidant status in prostate cancer patients: relation to Gleason score, treatment and bone metastasis.
    Battisti V; Maders LD; Bagatini MD; Reetz LG; Chiesa J; Battisti IE; Gonçalves JF; Duarte MM; Schetinger MR; Morsch VM
    Biomed Pharmacother; 2011 Oct; 65(7):516-24. PubMed ID: 21993000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
    Strohmeyer D; Strauss F; Rössing C; Roberts C; Kaufmann O; Bartsch G; Effert P
    Anticancer Res; 2004; 24(3a):1797-804. PubMed ID: 15274358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
    Shang ZJ; Li JR
    J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma].
    Yaylaci A; Cakir S; Güneş P; Akkaynak AC; Naiboğlu B; Gökçeer T
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(3):105-11. PubMed ID: 16763427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and prostate cancer: identification of a molecular progression switch.
    Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM
    Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
    Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
    Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.